Published in Anal Chem on October 15, 2002
Evaluation of unnatural cyclic amino acids as boron delivery agents for treatment of melanomas and gliomas. Appl Radiat Isot (2013) 0.81
Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging. Clin Cancer Res (2008) 1.96
Fluorescence lifetime imaging system for in vivo studies. Mol Imaging (2007) 1.83
Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA). Radiother Oncol (2008) 1.62
Potential of PET to predict the response to trastuzumab treatment in an ErbB2-positive human xenograft tumor model. J Nucl Med (2012) 1.52
[18F]FBEM-Z(HER2:342)-Affibody molecule-a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomography. Eur J Nucl Med Mol Imaging (2007) 1.50
Chromatographic alignment by warping and dynamic programming as a pre-processing tool for PARAFAC modelling of liquid chromatography-mass spectrometry data. J Chromatogr A (2002) 1.48
Changes in HER2 expression in breast cancer xenografts after therapy can be quantified using PET and (18)F-labeled affibody molecules. J Nucl Med (2009) 1.33
The crosstalk between EGF, IGF, and Insulin cell signaling pathways--computational and experimental analysis. BMC Syst Biol (2009) 1.24
Prediction of chromatographic retention and protein identification in liquid chromatography/mass spectrometry. Anal Chem (2002) 1.13
HSP90 inhibitor, DMAG, synergizes with radiation of lung cancer cells by interfering with base excision and ATM-mediated DNA repair. Mol Cancer Ther (2008) 1.13
Imaging prostate cancer: an update on positron emission tomography and magnetic resonance imaging. Curr Urol Rep (2010) 1.11
HER2- and EGFR-specific affiprobes: novel recombinant optical probes for cell imaging. Chembiochem (2010) 1.10
Quantitative analysis of Her2 receptor expression in vivo by near-infrared optical imaging. Mol Imaging (2010) 1.07
HER2-specific affibody-conjugated thermosensitive liposomes (Affisomes) for improved delivery of anticancer agents. J Liposome Res (2008) 1.05
DESIGN OF LIPOSOMES CONTAINING PHOTOPOLYMERIZABLE PHOSPHOLIPIDS FOR TRIGGERED RELEASE OF CONTENTS. J Therm Anal Calorim (2009) 1.04
Normal tissue protection for improving radiotherapy: Where are the Gaps? Transl Cancer Res (2012) 1.03
'Image and treat': an individualized approach to urological tumors. Curr Opin Oncol (2010) 1.03
Radiolabeling of HER2 specific Affibody(R) molecule with F-18. J Fluor Chem (2008) 0.99
Cerebrospinal fluid protein patterns in neurodegenerative disease revealed by liquid chromatography-Fourier transform ion cyclotron resonance mass spectrometry. Proteomics (2004) 0.99
Positron emission tomography/computed tomography and radioimmunotherapy of prostate cancer. Curr Opin Oncol (2009) 0.98
Affitoxin--a novel recombinant, HER2-specific, anticancer agent for targeted therapy of HER2-positive tumors. J Immunother (2009) 0.98
68Ga-DOTA-affibody molecule for in vivo assessment of HER2/neu expression with PET. Eur J Nucl Med Mol Imaging (2011) 0.97
Prostate specific membrane antigen- a target for imaging and therapy with radionuclides. Discov Med (2010) 0.97
Novel polyamine coating providing non-covalent deactivation and reversed electroosmotic flow of fused-silica capillaries for capillary electrophoresis. J Chromatogr A (2003) 0.97
Hyperthermia-triggered intracellular delivery of anticancer agent to HER2(+) cells by HER2-specific affibody (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2(+) affisomes). J Control Release (2011) 0.96
PET/CT Imaging and Radioimmunotherapy of Prostate Cancer. Semin Nucl Med (2011) 0.95
Quantitation of tryptophan, kynurenine and kynurenic acid in human plasma by capillary liquid chromatography-electrospray ionization tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.95
Peptide mapping of proteins in human body fluids using electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry. Mass Spectrom Rev (2002) 0.95
SimBoolNet--a Cytoscape plugin for dynamic simulation of signaling networks. Bioinformatics (2009) 0.95
In vivo fluorescence lifetime imaging monitors binding of specific probes to cancer biomarkers. PLoS One (2012) 0.94
Active targeting using HER-2-affibody-conjugated nanoparticles enabled sensitive and specific imaging of orthotopic HER-2 positive ovarian tumors. Small (2013) 0.93
A polyamine coating for enhanced capillary electrophoresis-electrospray ionization-mass spectrometry of proteins and peptides. Electrophoresis (2004) 0.91
Analysis of phosphatidylcholine and sphingomyelin molecular species from brain extracts using capillary liquid chromatography electrospray ionization mass spectrometry. J Neurosci Methods (2003) 0.90
Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study. J Neurooncol (2005) 0.89
Inverse treatment planning based on MRI for HDR prostate brachytherapy. Int J Radiat Oncol Biol Phys (2005) 0.89
HER2-affitoxin: a potent therapeutic agent for the treatment of HER2-overexpressing tumors. Clin Cancer Res (2011) 0.88
Sarcosine induces increase in HER2/neu expression in androgen-dependent prostate cancer cells. Mol Biol Rep (2011) 0.88
A new multi-residue method for analysis of pesticide residues in fruit and vegetables using liquid chromatography with tandem mass spectrometric detection. J Chromatogr A (2004) 0.88
Analysis of catecholamines and related substances using porous graphitic carbon as separation media in liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 0.87
In vivo method to monitor changes in HER2 expression using near-infrared fluorescence imaging. Mol Imaging (2012) 0.87
A novel 3D volumetric voxel registration technique for volume-view-guided image registration of multiple imaging modalities. Int J Radiat Oncol Biol Phys (2005) 0.87
Noncovalent interaction between amyloid-beta-peptide (1-40) and oleuropein studied by electrospray ionization mass spectrometry. J Am Soc Mass Spectrom (2006) 0.87
Radionuclide imaging of miniaturized chemical analysis systems. Anal Chem (2004) 0.87
Poly(dimethylsiloxane)-based microchip for two-dimensional solid-phase extraction-capillary electrophoresis with an integrated electrospray emitter tip. Anal Chem (2005) 0.85
Polylactide-based paclitaxel-loaded nanoparticles fabricated by dispersion polymerization: characterization, evaluation in cancer cell lines, and preliminary biodistribution studies. J Pharm Sci (2014) 0.85
Accuracy of 3D volumetric image registration based on CT, MR and PET/CT phantom experiments. J Appl Clin Med Phys (2008) 0.84
Affibody-DyLight conjugates for in vivo assessment of HER2 expression by near-infrared optical imaging. PLoS One (2012) 0.84
Capillary electrophoresis coupled to mass spectrometry from a polymer modified poly(dimethylsiloxane) microchip with an integrated graphite electrospray tip. Analyst (2005) 0.84
Capillary electrophoresis off-line matrix-assisted laser desorption/ionisation mass spectrometry of intact and digested proteins using cationic-coated capillaries. Rapid Commun Mass Spectrom (2004) 0.82
Quaternary ammonium substituted agarose as surface coating for capillary electrophoresis. Analyst (2004) 0.82
Targeted radionuclide therapy: proceedings of a joint workshop hosted by the National Cancer Institute and the Society of Nuclear Medicine and Molecular Imaging. J Nucl Med (2014) 0.82
Can PET imaging facilitate optimization of cancer therapies? Curr Pharm Des (2012) 0.81
A novel mass spectrometric approach to the analysis of hormonal peptides in extracts of mouse pancreatic islets. Eur J Biochem (2003) 0.80
Nanoscintillator conjugates as photodynamic therapy-based radiosensitizers: calculation of required physical parameters. Radiat Res (2009) 0.80
Fingerprinting metal-containing biomolecules after reductive displacement of iron by gallium and subsequent column-switched LC-ICPMS analysis applied on siderophores. Anal Chem (2004) 0.80
PET of HER2-positive pulmonary metastases with 18F-ZHER2:342 affibody in a murine model of breast cancer: comparison with 18F-FDG. J Nucl Med (2012) 0.79
Screening of microdialysates taken before and after induced liver damage; on-line solid phase extraction-electrospray ionization-mass spectrometry. J Chromatogr A (2006) 0.79
Ligand liposomes and boron neutron capture therapy. J Neurooncol (2003) 0.79
On-column polymer-imbedded graphite inlet electrode for capillary electrophoresis coupled on-line with flow injection analysis in a poly(dimethylsiloxane) interface. Electrophoresis (2003) 0.79
Proceedings of the Second NCI-SNMMI Workshop on Targeted Radionuclide Therapy. J Nucl Med (2015) 0.79
A comparison of the electrochemical stabilities of metal, polymer and graphite coated nanospray emitters. Analyst (2003) 0.79
The role of nuclear medicine in modern therapy of cancer. Tumour Biol (2012) 0.79
In vivo assessment of HER2 receptor density in HER2-positive tumors by near-infrared imaging, using repeated injections of the fluorescent probe. Technol Cancer Res Treat (2013) 0.78
On-line electrochemically controlled solid-phase extraction interfaced to electrospray and inductively coupled plasma mass spectrometry. Analyst (2005) 0.78
Electrochemical solid-phase microextraction of anions and cations using polypyrrole coatings and an integrated three-electrode device. Analyst (2002) 0.78
A conductive polymeric material used for nanospray needle and low-flow sheathless electrospray ionization applications. Anal Chem (2002) 0.78
Study of the non-covalent interaction between amyloid-beta-peptide and melatonin using electrospray ionization mass spectrometry. J Mass Spectrom (2005) 0.78
Rapid analysis of tryptically digested cerebrospinal fluid using capillary electrophoresis-electrospray ionization-Fourier transform ion cyclotron resonance-mass spectrometry. J Proteome Res (2003) 0.78
A simplified multidimensional approach for analysis of complex biological samples: on-line LC-CE-MS. Analyst (2006) 0.78
Accumulation of boron in human malignant glioma cells in vitro is cell type dependent. J Neurooncol (2004) 0.77
EGF-receptor targeted liposomes with boronated acridine: growth inhibition of cultured glioma cells after neutron irradiation. Int J Radiat Biol (2005) 0.77
Method for immobilization of liposomes in capillary electrophoresis by electrostatic interaction with derivatized agarose. Electrophoresis (2002) 0.77
Miniaturized on-line proteolysis-capillary liquid chromatography-mass spectrometry for peptide mapping of lactate dehydrogenase. J Chromatogr A (2003) 0.77
Protein identification in cerebrospinal fluid using packed capillary liquid chromatography Fourier transform ion cyclotron resonance mass spectrometry. Proteomics (2003) 0.77
Polyamine deactivation of integrated poly(dimethylsiloxane) structures investigated by radionuclide imaging and capillary electrophoresis experiments. Anal Chem (2005) 0.77
Influence of blood/tissue differences in contrast agent relaxivity on tracer-based MR perfusion measurements. MAGMA (2014) 0.76
Monomer surface modifications for rapid peptide analysis by capillary electrophoresis and capillary electrochromatography coupled to electrospray ionization-mass spectrometry. Electrophoresis (2004) 0.75
A chemometric study of active parameters and their interaction effects in a nebulized sheath-liquid electrospray interface for capillary electrophoresis-mass spectrometry. Electrophoresis (2004) 0.75
Monte Carlo model of the Studsvik BNCT clinical beam: description and validation. Med Phys (2003) 0.75
Total lipid extraction of homogenized and intact lean fish muscles using pressurized fluid extraction and batch extraction techniques. J Agric Food Chem (2005) 0.75
Use of an adsorbed chiral selector in capillary LC-MS. Chirality (2002) 0.75
Speciation of inositol phosphates in lake sediments by ion-exchange chromatography coupled with mass spectrometry, inductively coupled plasma atomic emission spectroscopy, and 31P NMR spectroscopy. Anal Chem (2015) 0.75
Quality assurance of patient dosimetry in boron neutron capture therapy. Acta Oncol (2004) 0.75
Multi-parameter investigation of tandem mass spectrometry in a linear ion trap using response surface modelling. J Mass Spectrom (2005) 0.75
Copolymeric (lR-trans)-N,N'-1,2-cyclohexylene-bisbenzamide oligodimethylsiloxane chiral stationary phase for gas chromatography. J Chromatogr A (2002) 0.75
On-line coupling of microdialysis to packed capillary column liquid chromatography-tandem mass spectrometry demonstrated by measurement of free concentrations of ropivacaine and metabolite from spiked plasma samples. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.75
On-line biological sample cleanup for electrospray mass spectrometry using sol-gel columns. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.75
Fast multi-element screening of non-digested biological materials by slurry introduction to ICP-AES. Talanta (2009) 0.75
Capillary column switching restricted-access media-liquid chromatography-electrospray ionization-tandem mass spectrometry system for simultaneous and direct analysis of drugs in biofluids. Anal Chem (2007) 0.75
Relating chromatographic retention and electrophoretic mobility to the ion distribution within electrosprayed droplets. J Am Soc Mass Spectrom (2006) 0.75
Introductory experiments on ligand liposomes as delivery agents for boron neutron capture therapy. Int J Oncol (2003) 0.75
Classification of lactate dehydrogenase of different origin by liquid chromatography-mass spectrometry and multivariate analysis. J Am Soc Mass Spectrom (2003) 0.75
Novel approach to the determination of structurally similar hydroxamate siderophores by column-switching capillary liquid chromatography coupled to mass spectrometry. J Chromatogr A (2003) 0.75
Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer. Oncotarget (2014) 0.75
Pressurised fluid extraction (PFE) as an alternative general method for the determination of pesticide residues in rape seed. Analyst (2002) 0.75